| Vol.
1 Issue 10 Friday, November 23, 2007 |
|
|
Commercial
Scale
Macrolides
Azithromycin
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin oxime (intermediate)
Erythromycin phosphate
Erythromycin propionate
Erythromycin stearate
Roxithromycin
Antitubercular
Pyrazinamide
Isoniazid
Rifampicin
Antimalarial
Artesunate
Arteether
Artemether
Dihydroartemisinin
Antihypertensive
Lisinopril dihydrate
Losartan potassium
Sedative, Hypnotic
Zopiclone
Antiosteoporotic
Alendronate sodium
Zoledronic acid
Antiepileptic
Sodium valproate
Valproic acid
Antidepressant
Venlafaxine hydrochloride
Antihistaminic
Cetirizine dihydrochloride
Antithrombotic
Clopidogrel bisulphate
Pilot Plant Scale
Carvedilol
Clarithromycin
Pioglitazone hydrochloride
Rosiglitazone maleate
Valsartan
R & D Scale
Lumefantrine
Pamidronate disodium
Perindopril erbumine
Zolpidem tartrate
Development
Benazepril hydrochloride
Candesartan
Desvenlafaxine
Glipizide
Irbesartan
Levocetirizine
Rifabutin
Rifapentine
Ramipril
Risedronic acid
Telmisartan
Product
under patent offered only
for exempted research, clinical
and
development purposes.
Only non-
infrining products
and processes
are offered, subject to
patent status
verification by client. |
|
Welcome
to our Stall at CPhI India 2007 !
Our
team of Sales, Business Development,
Purchase and R&D looks forward to
meeting you at Mumbai in this
year’s biggest Pharmaceutical Event
in India: “CPhI India 2007”
from 25 - 27 November 2007. We welcome our
valued partners - customers and suppliers at our
Stall No. B 12 in Hall 5. We also look forward
to meeting the other attendees with whom we may
not have had the opportunity to meet and discuss
business potentials. |
|
| |
The
words of CPhI India 2007 Organisers
“With an increasing GDP growth of 8.4%
to the year ending March 2005, India is predicted
to be one of the world’s top five economies by 2025.
The Indian pharmaceutical industry is a major part
of this development with a growing global
footprint
and specialization in all key parts of the clinical pipeline.
For the second time Mumbai is set to become the focal point
for this exciting industry – at CPhI India 2007.
CPhI India 2007 provides the ideal forum to meet with the best
in the industry and promote your business to customers who can
actively drive its growth. You can also discover
how the rapidly expanding Indian market with its
intelligent, expert workforce can provide a whole new
range of dynamic opportunities.
Held at the Bombay Exhibition Centre in Mumbai,
India from 25-27 November 2007. Visit CPhI India –
the perfect environment
for growth.”
Source :
www.cphi-india.com |
|
You too can be the winner at the Raffle
during CPhI India 2007 which we
have organized during 25 – 27 November
2007. VISIT US, HAVE DISCUSSIONS and DROP YOUR BUSINESS
CARD and you can be the lucky one. The winner
of this Raffle will be announced in our forthcoming newsletter
dated 7th December 2007.
|
|
Custom Syntheses Contract
Manufacturing FTE
Research
Analytical Support
APIs &
Intermediates
Building
Blocks
|
|
| |
Disclaimer:
"The information in this e-mail and any attachments
is confidential and may be legally privileged. It is intended solely
for the addressee or addressees. If you are not an intended recipient,
please delete the message and any attachments and
notify the sender of misdelivery. Any use or disclosure of the
contents of either is unauthorized and may be
unlawful. All liability for viruses is excluded to the
fullest extent permitted by law. Any views expressed
in this message are those of the individual sender, except where
the sender states them, with requisite authority, to be
those of the specific Calyx company." |
| To
unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com
|
| “Meet
us at
CPhI India 2007, at Bombay Exhibition Centre, Mumbai, India,
25 -
27 November 2007,
at Hall- 5, Stand No: B12” |
 |
|
